Journal ArticleOPEN ACCESS

COVID-19 vaccines: Keeping pace with SARS-CoV-2 variants

Cell (2021) 184(20) 5077-5081
DOI: 10.1016/j.cell.2021.09.010
100Citations
Citations of this article
141Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

As the SARS-CoV-2 pandemic evolves, new variants continue to emerge. Some highly transmissible variants, such as Delta, also raised concerns about the effectiveness provided by current vaccines. Understanding immunological correlates of protection and how laboratory findings correspond to clinical effectiveness is imperative to shape future vaccination strategies.

Cite

CITATION STYLE

APA

Cevik, M., Grubaugh, N. D., Iwasaki, A., & Openshaw, P. (2021). COVID-19 vaccines: Keeping pace with SARS-CoV-2 variants. Cell, 184(20), 5077–5081. https://doi.org/10.1016/j.cell.2021.09.010

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free